Literature DB >> 29769330

Activity-dependent aberrations in gene expression and alternative splicing in a mouse model of Rett syndrome.

Sivan Osenberg1, Ariel Karten1, Jialin Sun1, Jin Li2,3, Shaun Charkowick1, Christy A Felice1, Mary Kritzer4, Minh Vu Chuong Nguyen5, Peng Yu6,3, Nurit Ballas7.   

Abstract

Rett syndrome (RTT) is a severe neurodevelopmental disorder that affects about 1 in 10,000 female live births. The underlying cause of RTT is mutations in the X-linked gene, methyl-CpG-binding protein 2 (MECP2); however, the molecular mechanism by which these mutations mediate the RTT neuropathology remains enigmatic. Specifically, although MeCP2 is known to act as a transcriptional repressor, analyses of the RTT brain at steady-state conditions detected numerous differentially expressed genes, while the changes in transcript levels were mostly subtle. Here we reveal an aberrant global pattern of gene expression, characterized predominantly by higher levels of expression of activity-dependent genes, and anomalous alternative splicing events, specifically in response to neuronal activity in a mouse model for RTT. Notably, the specific splicing modalities of intron retention and exon skipping displayed a significant bias toward increased retained introns and skipped exons, respectively, in the RTT brain compared with the WT brain. Furthermore, these aberrations occur in conjunction with higher seizure susceptibility in response to neuronal activity in RTT mice. Our findings advance the concept that normal MeCP2 functioning is required for fine-tuning the robust and immediate changes in gene transcription and for proper regulation of alternative splicing induced in response to neuronal stimulation.

Entities:  

Keywords:  MeCP2; Rett syndrome; alternative splicing; gene expression; neuronal activity

Mesh:

Substances:

Year:  2018        PMID: 29769330      PMCID: PMC6003366          DOI: 10.1073/pnas.1722546115

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  46 in total

1.  Acute and crucial requirement for MeCP2 function upon transition from early to late adult stages of brain maturation.

Authors:  Fang Du; Minh Vu Chuong Nguyen; Ariel Karten; Christy A Felice; Gail Mandel; Nurit Ballas
Journal:  Hum Mol Genet       Date:  2016-02-16       Impact factor: 6.150

2.  Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2.

Authors:  Juan I Young; Eugene P Hong; John C Castle; Juan Crespo-Barreto; Aaron B Bowman; Matthew F Rose; Dongcheul Kang; Ron Richman; Jason M Johnson; Susan Berget; Huda Y Zoghbi
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-26       Impact factor: 11.205

3.  Misregulation of an Activity-Dependent Splicing Network as a Common Mechanism Underlying Autism Spectrum Disorders.

Authors:  Mathieu Quesnel-Vallières; Zahra Dargaei; Manuel Irimia; Thomas Gonatopoulos-Pournatzis; Joanna Y Ip; Mingkun Wu; Timothy Sterne-Weiler; Shinichi Nakagawa; Melanie A Woodin; Benjamin J Blencowe; Sabine P Cordes
Journal:  Mol Cell       Date:  2016-12-15       Impact factor: 17.970

4.  Transcriptional profiling of a mouse model for Rett syndrome reveals subtle transcriptional changes in the brain.

Authors:  Matthew Tudor; Schahram Akbarian; Richard Z Chen; Rudolf Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-13       Impact factor: 11.205

5.  Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state.

Authors:  Peter J Skene; Robert S Illingworth; Shaun Webb; Alastair R W Kerr; Keith D James; Daniel J Turner; Rob Andrews; Adrian P Bird
Journal:  Mol Cell       Date:  2010-02-26       Impact factor: 17.970

Review 6.  The story of Rett syndrome: from clinic to neurobiology.

Authors:  Maria Chahrour; Huda Y Zoghbi
Journal:  Neuron       Date:  2007-11-08       Impact factor: 17.173

7.  Intron retention is regulated by altered MeCP2-mediated splicing factor recruitment.

Authors:  Justin J-L Wong; Dadi Gao; Trung V Nguyen; Chau-To Kwok; Michelle van Geldermalsen; Rob Middleton; Natalia Pinello; Annora Thoeng; Rajini Nagarajah; Jeff Holst; William Ritchie; John E J Rasko
Journal:  Nat Commun       Date:  2017-05-08       Impact factor: 14.919

8.  MeCP2, a key contributor to neurological disease, activates and represses transcription.

Authors:  Maria Chahrour; Sung Yun Jung; Chad Shaw; Xiaobo Zhou; Stephen T C Wong; Jun Qin; Huda Y Zoghbi
Journal:  Science       Date:  2008-05-30       Impact factor: 47.728

9.  Disruption of DNA-methylation-dependent long gene repression in Rett syndrome.

Authors:  Harrison W Gabel; Benyam Kinde; Hume Stroud; Caitlin S Gilbert; David A Harmin; Nathaniel R Kastan; Martin Hemberg; Daniel H Ebert; Michael E Greenberg
Journal:  Nature       Date:  2015-03-11       Impact factor: 49.962

10.  Radically truncated MeCP2 rescues Rett syndrome-like neurological defects.

Authors:  Rebekah Tillotson; Jim Selfridge; Martha V Koerner; Kamal K E Gadalla; Jacky Guy; Dina De Sousa; Ralph D Hector; Stuart R Cobb; Adrian Bird
Journal:  Nature       Date:  2017-10-11       Impact factor: 49.962

View more
  14 in total

Review 1.  Convergence of spectrums: neuronal gene network states in autism spectrum disorder.

Authors:  Josefa M Sullivan; Silvia De Rubeis; Anne Schaefer
Journal:  Curr Opin Neurobiol       Date:  2019-06-18       Impact factor: 6.627

Review 2.  Autism spectrum disorder: insights into convergent mechanisms from transcriptomics.

Authors:  Mathieu Quesnel-Vallières; Robert J Weatheritt; Sabine P Cordes; Benjamin J Blencowe
Journal:  Nat Rev Genet       Date:  2019-01       Impact factor: 53.242

Review 3.  Intellectual and Developmental Disabilities Research Centers: A Multidisciplinary Approach to Understand the Pathogenesis of Methyl-CpG Binding Protein 2-related Disorders.

Authors:  Michela Fagiolini; Annarita Patrizi; Jocelyn LeBlanc; Lee-Way Jin; Izumi Maezawa; Sarah Sinnett; Steven J Gray; Sophie Molholm; John J Foxe; Michael V Johnston; Sakkubai Naidu; Mary Blue; Ahamed Hossain; Shilpa Kadam; Xinyu Zhao; Quiang Chang; Zhaolan Zhou; Huda Zoghbi
Journal:  Neuroscience       Date:  2020-04-29       Impact factor: 3.590

Review 4.  Therapeutic Modulation of RNA Splicing in Malignant and Non-Malignant Disease.

Authors:  Ettaib El Marabti; Omar Abdel-Wahab
Journal:  Trends Mol Med       Date:  2021-05-13       Impact factor: 15.272

5.  Specification of Drosophila neuropeptidergic neurons by the splicing component brr2.

Authors:  Ignacio Monedero Cobeta; Caroline Bivik Stadler; Jin Li; Peng Yu; Stefan Thor; Jonathan Benito-Sipos
Journal:  PLoS Genet       Date:  2018-08-22       Impact factor: 5.917

Review 6.  MeCP2: The Genetic Driver of Rett Syndrome Epigenetics.

Authors:  Katrina V Good; John B Vincent; Juan Ausió
Journal:  Front Genet       Date:  2021-01-21       Impact factor: 4.599

7.  Environmental enrichment preserves a young DNA methylation landscape in the aged mouse hippocampus.

Authors:  Sara Zocher; Rupert W Overall; Mathias Lesche; Andreas Dahl; Gerd Kempermann
Journal:  Nat Commun       Date:  2021-06-23       Impact factor: 14.919

8.  A data mining paradigm for identifying key factors in biological processes using gene expression data.

Authors:  Jin Li; Le Zheng; Akihiko Uchiyama; Lianghua Bin; Theodora M Mauro; Peter M Elias; Tadeusz Pawelczyk; Monika Sakowicz-Burkiewicz; Magdalena Trzeciak; Donald Y M Leung; Maria I Morasso; Peng Yu
Journal:  Sci Rep       Date:  2018-06-13       Impact factor: 4.379

9.  RBPMetaDB: a comprehensive annotation of mouse RNA-Seq datasets with perturbations of RNA-binding proteins.

Authors:  Jin Li; Su-Ping Deng; Jacob Vieira; James Thomas; Valerio Costa; Ching-San Tseng; Franjo Ivankovic; Alfredo Ciccodicola; Peng Yu
Journal:  Database (Oxford)       Date:  2018-01-01       Impact factor: 3.451

10.  MeCP2 gates spatial learning-induced alternative splicing events in the mouse hippocampus.

Authors:  David V C Brito; Kubra Gulmez Karaca; Janina Kupke; Lukas Frank; Ana M M Oliveira
Journal:  Mol Brain       Date:  2020-11-17       Impact factor: 4.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.